Post-Craniotomy Pain Management: Beyond Opioids

Area of Science:

• Neurosurgery
• Anesthesiology
• Pain Management

Background:

• Craniotomy pain is frequently severe and undertreated.
• Effective pain management balances analgesia with avoiding side effects like sedation and respiratory depression.
• Opioid use is limited due to concerns about neurological assessment interference and increased intracranial pressure.

Purpose of the Study:

• To review current strategies for managing post-craniotomy pain.
• To explore the role of non-opioid analgesics and novel agents in multimodal pain management.
• To highlight the challenges and considerations in achieving adequate analgesia while minimizing adverse effects.

Main Methods:

• Review of current literature on post-craniotomy pain management.
• Analysis of the benefits and limitations of opioid and non-opioid analgesic strategies.
• Evaluation of regional scalp blocks, paracetamol, NSAIDs, dexmedetomidine, gabapentinoids, and ketamine.

Main Results:

• Non-opioid analgesics are beneficial for multimodal post-craniotomy pain management.
• Regional scalp blocks, paracetamol, and NSAIDs are effective in the early post-operative period.
• Novel analgesics like dexmedetomidine, gabapentinoids, and ketamine show promise but require further research.

Conclusions:

• Multimodal pain management is crucial for post-craniotomy pain.
• Non-opioid strategies offer a safer alternative to opioids, especially in neurosurgery.
• Further investigation into novel analgesics is warranted to optimize post-craniotomy pain control.